In particular, it has been reported that CD123 is expressed on both LSCs and more differentiated leukaemic blasts [5, 6]; in addition, a correlation between CD123 expression on AML LSCs and poor prognosis due to resistance to traditional chemotherapy has been found [7]. Here, IL3RA is linked to acute myeloid leukemia.